Multiple Heart-Cutting and Comprehensive 2D-LC Analysis of Biopharmaceuticals

contributed by Agilent Technologies | 12/01/2014

Online 2D-LC analysis of complex N-Glycans for highest resolution using the Agilent 1290 Infinity 2D-LC solution.

Erythropoietin (EPO) is a 30400 dalton (Da) glycoprotein hormone that regulates the production of red blood cells (erythropoiesis). The glycosylation of EPO is highly variable because it contains multiple glycosylation sites, each of which can have a wide variety of glycan structures. This results in a huge complexity of glycan structures that is referred to as microheterogeneity.

Recombinant human EPO (rhEPO) has proven to be highly efficient in the treatment of different diseases such as anemias associated with cancer, chronic renal failure and HIV infection.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.